EGI
NBP

EAM Global Investors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

EAM Global Investors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-63,064
Closed -$5.29M – 218
2021
Q2 		$5.29M Buy
+63,064
New +$4.16M 1.47% 3

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ZAM
Zeal Asset Management Central, Hong Kong $39.4M AUM 38.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

EAM Global Investors's NBP Position: Q3 2021 in Review

EAM Global Investors sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2021, closing a stake of 63,064 shares — an estimated $5.29M sold.

EAM Global Investors first reported a position in NBP in Q2 2021 and held it in 1 quarter. The position peaked at $5.29M in Q2 2021. 144 funds tracked by Wall St. Rank hold NBP as of Q3 2021.

  • EAM Global Investors reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • EAM Global Investors sold 63,064 NovaBridge Biosciences American Depositary Shares shares in Q3 2021, an estimated $5.29M.
  • EAM Global Investors first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 1 quarter.
  • EAM Global Investors's NovaBridge Biosciences American Depositary Shares position peaked at $5.29M in Q2 2021.
  • 144 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.